Last reviewed · How we verify

NCT03317964

Genetic Basis of Pacing-induced Cardiomyopathy

Completed Last updated 22 June 2025
What this trial tests

trial testing Saliva sample in Pacemaker, Artificial in 153 participants. Completed in 19 June 2025.

Timeline
16 October 2017
Primary endpoint
19 June 2025
19 June 2025

Quick facts

Lead sponsorThe Guthrie Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment153
Start date16 October 2017
Primary completion19 June 2025
Estimated completion19 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Guthrie Clinic

Who can join

18 and older, any sex, with Pacemaker, Artificial or Cardiomyopathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to collect a saliva sample from patients with a pacemaker to study genes involved in cardiomyopathy, a condition where the heart muscle is abnormal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Saliva sample

Trials testing the same drug.

Other recruiting trials for Pacemaker, Artificial

Currently open trials in the same condition.

Other The Guthrie Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03317964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing